The Perth medtech sector is often a silent, yet potent, sector.
Startup News has been covering countless medtech successes of the years, including Rex Ortho, which in 2019, raised $1.15 million for their orthopaedic screw.
In more recent times, Singular Health, a Subiaco-based medtech company, had an IPO (initial public offering) earlier this year, the then 20 cent per security offering saw the company market cap around $20 million.
The company hit a high of almost 70 cents per share in mid-March, trading under the ‘SHG’ ticker, with shares settling back at 37.5 this week, well above their IPO price.
Perth has also produced other world leading companies such as VeinTech, the startup that recently won the $10,000 Medtronic Prize in the prestigious 2021 MedTech Actuator Origin pitch, a tightly contested Asia-Pacific wide competition.
And then of course there is OncoRes Medical, who has developed a hand-held scanner for surgeons during breast cancer surgery to ensure all the cancer is removed. CEO Dr Kath Giles even won a global pitch competition in 2018 over the UK and raised $1M in grant funding in 2020.
It certainly seems then that Perth is the perfect place for a top medical conference.
The conference details
The International Congress of Neuromuscular Diseases returns to Perth in 2024; it was last here way back in 1971.
One of the leading global conferences of its kind, some of the topics to be discussed includes the latest developments in the treatments for neuromuscular diseases such as Duchenne muscular dystrophy.
Western Australia is currently home to more than 40 established medical and life science organisations, including the Perron Institute for Neurological and Translational Science.
The WA state government is also considering it a boon for local tourism, the Government said in a statement “in 2019-20, Business Events Perth secured 124 conferences and 125 corporate meetings and incentive events for the year, injecting close to $141 million into WA’s economy.”
